retatrutide mechanism triple agonist glp-1 gip glucagon glp 1 agonists Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence Healthy Weight Medication:Tirzepatide (GLP-1 + GIP) glp 1 agonist comparison

retatrutide mechanism triple agonist glp-1 gip glucagon glp 1 agonists Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence Healthy Weight Medication:Tirzepatide (GLP-1 + GIP) glp 1 agonist comparison

glp 1 agonist comparison Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology

Losing excess weight can enhance insulin sensitivity, reduce inflammation, and improve cardiovascular health

Healthy Weight

Medication:Tirzepatide (GLP-1 + GIP)

[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Rosenbaum M, Leibel RL